Evidence map›Paper›PMID 18368410›Full record

ArticleRheumatology international2008

Serotonin mediates PGE2 overexpression through 5-HT2A and 5-HT3 receptor subtypes in serum-free tissue culture of macrophage-like synovial cells.

Matthias F Seidel, Bernd L Fiebich, Gudrun Ulrich-Merzenich, Eduardo Candelario-Jalil, Franz-Walter Koch, Hans Vetter

Abstract read
PubMed Publisher
In one paragraph

Article in Rheumatology international, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 43 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Tapping into 5-HTInternational journal of molecular sciences · 2021
    Review
  9. Article
  10. Pathological Insight into 5-HTInternational journal of molecular sciences · 2020
    Review
  11. Review
  12. Review
  13. The Effects of Serotonin in Immune Cells.Frontiers in cardiovascular medicine · 2017
    Review
  14. Article
  15. Immunomodulatory effects mediated by serotonin.Journal of immunology research · 2015
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Matthias F SeidelRheumatology, Medizinische Universitäts-Poliklink, Bonn, Germany. Matthias.Seidel@ukb.uni-bonn.de
Bernd L Fiebich
Gudrun Ulrich-Merzenich
Eduardo Candelario-Jalil
Franz-Walter Koch
Hans Vetter
University Hospital Bonn · DEUniversity Medical Center Freiburg · DESt. Josefs Hospital · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin antagonists show impressive analgesic efficacy in rheumatoid arthritis, osteoarthritis (OA) or fibromyalgia; however, this effect is not well understood. We examined the mechanism of serotonin-induced inflammation and its antagonists in OA. Serotonin receptor subtypes and COX-2 were analysed by RT-PCR from synovial tissue. Serum-free cultures were stimulated with 10 muM serotonin and/or the antagonists ketanserin (5-HT(2A)), tropisetron (5-HT(3)) and parecoxib (COX-2). Prostaglandin E(2) (PGE(2)), tumour necrosis factor alpha (TNF-alpha), interleukin 1beta (IL-1beta) and leukotriene B4 (LTB4) were measured by an immunoassay in the supernatants. RT-PCR results showed mRNA for 5-HT(2A) and 5-HT(3) receptors, and COX-2. PGE(2) in the supernatants increased by 261.2% +/- 56.7 (mean +/- SEM; P = 0.007) in response to serotonin. TNF-alpha, IL-1beta and LTB4 levels did not change. Ketanserin, tropisetron and parecoxib suppressed PGE(2). The serotonin-induced PGE(2) overexpression appeared thus to be mediated by 5-HT(2A) and 5-HT(3) receptors. This activation might involve COX-2. The findings may explain the potent benefit of 5-HT(3) antagonists.

Indexed as

AgedCells, CulturedCulture Media, Serum-FreeCyclooxygenase 2Cyclooxygenase InhibitorsDinoprostoneDrug InteractionsHumansIndolesInterleukin-1betaIsoxazolesKetanserinLeukotriene B4MacrophagesMiddle AgedOsteoarthritisCulture Media, Serum-FreeCyclooxygenase 2Cyclooxygenase InhibitorsDinoprostoneIndolesInterleukin-1betaIsoxazolesKetanserinLeukotriene B4parecoxibReceptor, Serotonin, 5-HT2AReceptors, Serotonin, 5-HT3RNA, MessengerSerotoninSerotonin AgentsSerotonin AntagonistsTropisetronTumor Necrosis Factor-alpha

Identifiers

PMID18368410
OpenAlexW2008673308

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.